Nicoletta Colombo, MD, PhD, discusses why metronomic chemotherapy dosing and careful regimen design may have driven the success of the KEYNOTE-B96 trial.
Nicoletta Colombo, MD, PhD
Advertisement
Articles by Nicoletta Colombo, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Addressing Drug Resistance in Lung Cancer
5
